Aycicek, G. S. Et Al. 2018. Clinical Impact of p27 Kip1 and CaSR Expression on Primary Hyperparathyroidism. ENDOCRINE PATHOLOGY , vol.29, no.3 , 250-258.

Aycicek, G. S., Aydogan, B. I., ŞAHİN, M., CANSIZ ERSÖZ, C., SAK, S., & Baskal, N., (2018). Clinical Impact of p27 Kip1 and CaSR Expression on Primary Hyperparathyroidism. ENDOCRINE PATHOLOGY , vol.29, no.3, 250-258.

Aycicek, Gozde Et Al. "Clinical Impact of p27 Kip1 and CaSR Expression on Primary Hyperparathyroidism," ENDOCRINE PATHOLOGY , vol.29, no.3, 250-258, 2018

Aycicek, Gozde S. Et Al. "Clinical Impact of p27 Kip1 and CaSR Expression on Primary Hyperparathyroidism." ENDOCRINE PATHOLOGY , vol.29, no.3, pp.250-258, 2018

Aycicek, G. S. Et Al. (2018) . "Clinical Impact of p27 Kip1 and CaSR Expression on Primary Hyperparathyroidism." ENDOCRINE PATHOLOGY , vol.29, no.3, pp.250-258.

@article{article, author={Gozde Sengul Aycicek Et Al. }, title={Clinical Impact of p27 Kip1 and CaSR Expression on Primary Hyperparathyroidism}, journal={ENDOCRINE PATHOLOGY}, year=2018, pages={250-258} }